Viewing Study NCT02486718


Ignite Creation Date: 2025-12-25 @ 5:00 AM
Ignite Modification Date: 2025-12-26 @ 4:00 AM
Study NCT ID: NCT02486718
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2025-10-10
First Post: 2015-06-04
Is NOT Gene Therapy: False
Has Adverse Events: True

Brief Title: Study to Assess Safety and Efficacy of Atezolizumab (MPDL3280A) Compared to Best Supportive Care Following Chemotherapy in Patients With Lung Cancer [IMpower010]
Sponsor: Hoffmann-La Roche
Organization: